The weekly litigation news digest is live. Subscribe now

IP Verse

Insulinotropic And Glucagonotropic Effects Of Beta-Lactoglobulin - EP4061399

The patent EP4061399 was granted to Arla Foods Amba on Feb 14, 2024. The application was filed on Nov 20, 2020 under application number EP20808127A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4061399

ARLA FOODS AMBA
Application Number
EP20808127A
Filing Date
Nov 20, 2020
Status
Granted And Under Opposition
Jan 12, 2024
Publication Date
Feb 14, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ZIMMERMANN & PARTNER PATENTANWALTE MBBNov 14, 2024ZIMMERMANN & PARTNER PATENTANWALTE MBBADMISSIBLE
NUTRICIANov 13, 2024NEDERLANDSCH OCTROOIBUREAUADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2017EP84553
DESCRIPTIONWO2019EP67015
DESCRIPTIONWO2018115520
DESCRIPTIONWO2020002426
INTERNATIONAL-SEARCH-REPORTUS2018153964
INTERNATIONAL-SEARCH-REPORTWO2010037736
OPPOSITIONUS2018153964
OPPOSITIONWO2020001765

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents